Insmed Inc (NASDAQ: INSM) stock enjoyed a major increase of 10.7% on 11/19/24. The shares closed at $73.72. Moreover, trading volume in this advance was unusually high at 190% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 2.6% during the last week.
Current PriceTarget Research Rating
Insmed is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment